跳至主要内容
临床试验/NCT06257654
NCT06257654已完成不适用

One-year Results After Single-center Water Vapor Thermal Therapy for Symptomatic Benign Prostatic Hyperplasia.

Hisar Intercontinental Hospital2 个研究点 分布在 1 个国家目标入组 71 人开始时间: 2021年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
71
试验地点
2
主要终点
q max

研究概览

简要总结

Objective: Rezūm vapor ablation is a minimally invasive treatment for benign prostatic hyperplasia (BPH) that uses injections of sterile water vapor directly into the prostate for tissue ablation. Although Rezūm is currently indicated for use in men with prostate sizes ≥30 and ≤80 ml, it is unclear how effective Rezūm is for men in urinary retention. The investigators sought to determine whether Rezūm is effective in the treatment of catheter-dependent urinary retention secondary to BPH.

详细描述

The data of participants who underwent Rezūm operation with the diagnosis of BPH between 2021 and 2023 were evaluated retrospectively. The investigators evaluated procedure details and evaluated pre- and post-Rezūm (including International Prostate Symptom Score (IPSS), IPSS quality of life (IPSS-QOL), prostate volumes, maximum flow (Qmax), post-void residual urine volume, IEEF-5, ejaculation dysfunction). The investigators examined variables at 6 and 12 months).

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
40 Years 至 100 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Benign prostatic hyperplasia

排除标准

  • Prostate cancer
  • Parkinson's disease,
  • Neurogenic bladder
  • Overactive bladder
  • Bladder calculus,
  • Bladder Tumor
  • Urinary infection
  • Alzheimer's disease

结局指标

主要结局

q max

时间窗: 1 years

ml/sn

quality of life index

时间窗: 1 years

Scoring from 1-4, An increase in the quality of life means an increase in the score, or a decrease in the quality of life means a decrease in the score.

International Prostate Symptom Score,

时间窗: 1 years

Scoring from 1-35, An increase in symptoms means an increase in the score, or a decrease in symptoms means a low score.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Basri Cakiroglu

Ass. Prof.

Hisar Intercontinental Hospital

研究点 (2)

Loading locations...

相似试验

One-year Results After Single-center Water Vapor... | 临床试验